Journal IJCRT UGC-CARE, UGCCARE( ISSN: 2320-2882 ) | UGC Approved Journal | UGC Journal | UGC CARE Journal | UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, International Peer Reviewed Journal and Refereed Journal, ugc approved journal, UGC CARE, UGC CARE list, UGC CARE list of Journal, UGCCARE, care journal list, UGC-CARE list, New UGC-CARE Reference List, New ugc care journal list, Research Journal, Research Journal Publication, Research Paper, Low cost research journal, Free of cost paper publication in Research Journal, High impact factor journal, Journal, Research paper journal, UGC CARE journal, UGC CARE Journals, ugc care list of journal, ugc approved list, ugc approved list of journal, Follow ugc approved journal, UGC CARE Journal, ugc approved list of journal, ugc care journal, UGC CARE list, UGC-CARE, care journal, UGC-CARE list, Journal publication, ISSN approved, Research journal, research paper, research paper publication, research journal publication, high impact factor, free publication, index journal, publish paper, publish Research paper, low cost publication, ugc approved journal, UGC CARE, ugc approved list of journal, ugc care journal, UGC CARE list, UGCCARE, care journal, UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, ugc care list of journal, ugc care list 2020, ugc care approved journal, ugc care list 2020, new ugc approved journal in 2020, ugc care list 2021, ugc approved journal in 2021, Scopus, web of Science.
How start New Journal & software Book & Thesis Publications
Submit Your Paper
Login to Author Home
Communication Guidelines

WhatsApp Contact
Click Here

  Published Paper Details:

  Paper Title

CRISPR-CAS9: A groundbreaking approach for human disease rehabilitation

  Authors

  Aditi Patil,  Dr. Shivani Kakkar Khanna,  Dr. Pooja Gupta

  Keywords

Crispr-cas9, Cancer, Neurological disease, Genome, DNA editing, Cystic fibrosis, Targeted Drug Delivery, Genome Engineering, human disease.

  Abstract


ABSTRACT: The field of medicine and research can greatly benefit from the application of genetic engineering. The Cas-9 protein and clustered regularly interspaced short palindromic repeats (CRISPR) are linked to a groundbreaking method in genetic engineering that allows for precise gene editing. CRISPR/Cas9 is an RNA domain-containing endonuclease-based genome engineering tool that has showed potential in cancer rehabilitation owing to its high precision, accuracy, time-saving, and cost-effective tactics. It has been utilized to enhance the clinical condition of Huntington's disease (HD), a rare neurological ailment caused by a CAG trinucleotide increase in the Huntingtin gene. It is distinguished by the considerable penetration of a single mutation, and it has been used to repair CF-causing mutations, making them effective therapeutic agents for combating HIV and other infectious diseases. In recent years, RNA-editing technologies based on clustered regularly interspaced short palindromic repeats (CRISPR)-associated nucleases 9 (CAS9) have come to light as potential treatments for this insidious illness. In this article the problem statement is find out how crispr cas 9 technology is used for effective treatment of various human diseases. Diseases to be covered in this article are cancer, huntington's disease, cystic fibrosis, human immunodeficiency virus (hiv) and alzheimers disease.

  IJCRT's Publication Details

  Unique Identification Number - IJCRT24A4582

  Paper ID - 258236

  Page Number(s) - n667-n674

  Pubished in - Volume 12 | Issue 4 | April 2024

  DOI (Digital Object Identifier) -   

  Publisher Name - IJCRT | www.ijcrt.org | ISSN : 2320-2882

  E-ISSN Number - 2320-2882

  Cite this article

  Aditi Patil,  Dr. Shivani Kakkar Khanna,  Dr. Pooja Gupta,   "CRISPR-CAS9: A groundbreaking approach for human disease rehabilitation", International Journal of Creative Research Thoughts (IJCRT), ISSN:2320-2882, Volume.12, Issue 4, pp.n667-n674, April 2024, Available at :http://www.ijcrt.org/papers/IJCRT24A4582.pdf

  Share this article

  Article Preview

  Indexing Partners

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
Call For Paper July 2024
Indexing Partner
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
DOI Details

Providing A Free digital object identifier by DOI.one How to get DOI?
For Reviewer /Referral (RMS) Earn 500 per paper
Our Social Link
Open Access
This material is Open Knowledge
This material is Open Data
This material is Open Content
Indexing Partner

Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 7.97 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer